Literature DB >> 30906913

Balancing RAF, MEK, and EGFR inhibitor doses to achieve clinical responses and modulate toxicity in BRAF V600E colorectal cancer.

Sebastian Mondaca1, Mario Lacouture2, Jonathan Hersch1, Rona Yaeger1.   

Abstract

Entities:  

Year:  2018        PMID： 30906913      PMCID： PMC6428446          DOI： 10.1200/PO.18.00088

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  1 in total

1.  Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy.

Authors:  Amin Zargar; Samantha Chang; Ankita Kothari; Antoine M Snijders; Jian-Hua Mao; Jessica Wang; Amanda C Hernández; Jay D Keasling; Trever G Bivona
Journal:  Chronic Dis Transl Med       Date:  2020-01-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.